<DOC>
	<DOCNO>NCT01383967</DOCNO>
	<brief_summary>This two part study . Part A multiple-ascending dose study 6 different group healthy subject , approximately 12 subject group . Part A allow investigation 6 different dos LY2979165 . The drug administer total 14 day . Subjects resident clinical research unit ( CRU ) Day -1 ( day dose ) Day 15 . Part B investigate dose LY2979165 previously administer Part A 12 subject . The drug administer total 14 day . In addition assessment would complete Part A , subject Part B also cerebrospinal fluid sample take low lumbar region spine .</brief_summary>
	<brief_title>A Study LY2979165 Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Bipolar Disorder</mesh_term>
	<criteria>Are overtly healthy male female , determine medical history physical examination . Female subject Part B ( perform ) site 's discretion . Male subject : Agree use reliable method birth control study Female subject : Women childbearing potential due surgical sterilisation ( hysterectomy bilateral oophorectomy tubal ligation ) postmenopausal define age great equal 45 year , intact uterus , take hormone oral contraceptive &gt; 1 year , either : Spontaneous amenorrhoea &gt; 12 month , Spontaneous amenorrhoea 612 month folliclestimulating hormone ( FSH ) level &gt; 40 mIU/mL Are body mass index ( BMI ) 18.5 29.9 kg/m^2 , inclusive Have clinical laboratory test result within normal reference range population investigator site , result acceptable deviation judge clinically significant investigator Have venous access sufficient allow blood sample per protocol Are reliable willing make available duration study willing follow study procedure Have give write informed consent approve Lilly ethical review board ( ERB ) govern site Are currently enrol , complete discontinue within last 30 day , clinical trial involve investigational product investigational product use study ; concurrently enrol type medical research judge scientifically medically compatible study History clinically significant adverse drug reaction `` drug allergy '' 3 different type systemically administer medication ( penicillin cephalosporin may consider 1 type medication purpose ) know allergy LY2979165 's constituent Are person previously complete withdrawn study study investigate LY2979165 Have Bazett 's correct QT ( QTcB ) interval value &gt; 450 msec ( male ) &gt; 470 msec ( female ) abnormality screen 12lead ECG , opinion investigator , increase risk associate participate study Have abnormal blood pressure ( least 5 minute supine position ) determine investigator Have history presence cardiovascular , respiratory , hepatic , renal , gastrointestinal , endocrine , haematological , immunological , neurological disorder capable significantly alter absorption , metabolism , elimination drug ; constitute risk take study medication ; interfere interpretation data Show evidence significant active neuropsychiatric disease Have increase risk seizure evidence history : great equal one ( 1 ) seizure ( except childhood febrile seizure ) , history electroencephalogram epileptiform activity , history stroke ; surgery cerebral cortex ; head trauma loss consciousness Have history alcohol drug abuse Show evidence human immunodeficiency virus ( HIV ) and/or positive human HIV antibody Show evidence hepatitis B and/or positive hepatitis B surface antigen Intended use overthecounter medication within 7 day prior dose study exception vitamins mineral supplement ( provide &gt; 100 % recommend dietary allowance [ RDA ] ) , occasional paracetamol acetaminophen . If situation arises , inclusion otherwise suitable subject may discretion sponsor . Intended use herbal supplement prescription medication , stable dos thyroid estrogen hormone replacement , within 14 day prior dose study . If situation arises , inclusion otherwise suitable subject may discretion sponsor . Have donate blood 450 mL within last 3 month Subjects meet least 1 follow criterion ( 1 unit = 12 oz 360 mL beer ; 5 oz 150 mL wine ; 1.5 oz 45 mL distilled spirit ) : ) subject average weekly alcohol intake exceed 21 unit per week ( male ) 14 unit per week ( female ) , b ) subject unwilling stop alcohol consumption 48 hour prior dose completion 14day dosing period , c ) subject unwilling limit alcohol intake 3 unit per day time study . Cigarette consumption 10 cigarette per day unable/unwilling abide CRU smoke restriction admission Any condition , opinion investigator , would preclude participation study Additional criterion Part B : Abnormalities lumbar spine previously know determined screen lumbar xray ( conduct ) . History clinically significant back pain , back pathology and/or back injury ( example , degenerative disease , spinal deformity spinal surgery ) may predispose complication technical difficulty lumbar puncture Have evidence history significant active bleeding coagulation disorder take nonsteroidal anti inflammatory drug drug affect coagulation platelet function within 14 day prior lumbar catheter insertion Have allergy lidocaine ( XylocaineÂ® ) derivative Have medical surgical condition lumbar puncture contraindicate</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2012</verification_date>
</DOC>